Drupal.behaviors.print = function(context) {window.print();window.close();}>

Nimbus Receives Additional Funding to Further Develop Protein Targets for Drug Development

March 10, 2011

Nimbus Receives Additional Funding to Further Develop Protein Targets for Drug Development

The funds will be used to advance the company's lead programs in diffuse large B-cell lymphoma, inflammatory disorders, and metabolic disease.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories